Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination.
Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Supportive or detrimental roles of P2Y receptors in brain pathology?-The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.
The Impact of Increasing Multiple Sclerosis (Ms) Severity Level on Employment and Caregiver Burden.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Multisystem involvement in neuromyelitis optica.
1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Chemokine receptor expression by inflammatory T cells in EAE.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
From the fundamentals of multiple sclerosis to clinical management.
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Diagnostic criteria for pediatric multiple sclerosis.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Endogenous recovery after brain damage; molecular mechanisms that balance neuronal life/death fate.
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »